Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: AstraZeneca's tozorakimab meets primary endpoint in COPD

Lucid Diligence Brief: AstraZeneca's tozorakimab meets primary endpoint in……


Onco_background

Oncology Today—March 23, 2026

This week’s Oncology update highlights EU regulatory expansion, late-stage…


Women's_Health

Women’s Health Today—March 18, 2026

This biweekly Women’s Health update highlights regulatory momentum, late-stage…


Immunology

Immunology Today—March 18, 2026

This week’s Immunology update highlights regulatory progress, late-stage…


Onco_background

Oncology Today—March 16, 2026

This week’s Oncology update highlights regulatory progress, pivotal-intent…


Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap—March 11, 2026

This biweekly AI in Healthcare and Digital Health video recap highlights safety…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—March 9, 2026

This week’s Artificial Intelligence and Digital Health update highlights…


Oncology News

Oncology Video Recap—March 2, 2026

This biweekly Oncology and Biopharma Regulatory Watch video recap highlights…


Respiratory

Respiratory Today—February 27, 2026

This week’s Respiratory update highlights regulatory milestones, late-stage…


Endocrinology

Endocrinology Today—February 24, 2026

This week's Endocrinology update covers guideline and labeling changes,…


Hematology

Hematology Video Recap—February 23, 2026

Hematology biweekly video covering key regulatory actions and clinical program…


Hematology

Hematology Today—February 23, 2026

This week's Hematology update covers key regulatory actions and clinical…


Privacy Preference Center